Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8622
Gene Symbol: PDE8B
PDE8B
0.400 Biomarker phenotype CTD_human Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene. 20085714 2010
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.400 Biomarker phenotype CTD_human Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency. 17368676 2007
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.400 Biomarker phenotype HPO
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.400 GeneticVariation phenotype CLINVAR
Entrez Id: 8622
Gene Symbol: PDE8B
PDE8B
0.400 Biomarker phenotype HPO
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.300 Biomarker phenotype CTD_human Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. 15570195 2004
Entrez Id: 4852
Gene Symbol: NPY
NPY
0.300 Therapeutic phenotype CTD_human Microinjection of NPY (160 pmol) into the areas adjacent to the LC did not attenuate the rigidity. 10675796 2000
Entrez Id: 4922
Gene Symbol: NTS
NTS
0.300 Therapeutic phenotype CTD_human These results suggest that NT may interact with the mu-opioid receptors at the LC, resulting in the suppression of fentanyl-induced muscular rigidity in the rat. 8036282 1994
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.140 Biomarker phenotype BEFREE In patients with DAT deficits, reduced facial expression was associated with DAT deficiency specifically in the caudate nucleus, and increased upper extremity rigidity was associated with DAT loss in the dorsal putamen (FWE-corrected P < 0.05). 30687897 2019
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.140 Biomarker phenotype BEFREE Fifty-six patients (52.8%) were diagnosed as having concomitant parkinsonism with rigidity and resting tremor and dopamine transporter reduction in the basal ganglia. 30222946 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.140 Biomarker phenotype BEFREE Striatal DAT binding correlated with akinesia-rigidity (P < 0.001) but not with tremor; the metabolic PET imaging, nonspecific to the dopaminergic dysfunction, disclosed a set of brain regions correlating with the cardinal symptoms, including tremor. 29863572 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.140 Biomarker phenotype BEFREE The left CR score was associated with left arm bradykinesia and rigidity scores and DAT uptake in the right posterior putamen, whereas no such associations were found for the right CR score. 29971496 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.140 Biomarker phenotype HPO
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.130 GeneticVariation phenotype BEFREE Several mutations in leucine rich repeat kinase 2 (LRRK2) gene have been associated with pathogenesis of Parkinson's disease (PD), a neurodegenerative disorder marked by resting tremors, and rigidity, leading to Postural instability. 29482628 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.130 GeneticVariation phenotype BEFREE Based on motor Unified Parkinson's Disease Rating Scale subscores, MAPT (P = .0002) and CCDC62 (P = .003) were predominantly associated with bradykinesia, and we further discovered associations between SREBF1 (rs11868035; P = .005) and gait impairment, SNCA (rs356220; P = .04) and rigidity, and GAK (rs1564282; P = .03) and tremor. 24514572 2014
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.130 GeneticVariation phenotype BEFREE More LRRK2 G2019S carriers reported muscle stiffness (rigidity, p = 0.007) and balance disturbances (p = 0.008), while more GBA mutation carriers reported slowness (bradykinesia, p = 0.021). 19458969 2010
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.130 GeneticVariation phenotype BEFREE They had significantly more symmetric signs and less rigidity than ADP caused by the G2019S mutation in LRRK2 or by unknown mutations. 17568014 2007
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.130 GeneticVariation phenotype BEFREE The tau gene has been found to be the locus of dementia with rigidity linked to chromosome 17. 10374757 1999
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.130 GeneticVariation phenotype BEFREE Frontotemporal dementia with parkinsonism, chromosome 17 type (FTDP-17), a recently defined disease entity, is clinically characterized by personality changes sometimes associated with psychosis, hyperorality, and diminished speech output, disturbed executive function and nonfluent aphasia, bradykinesia, and rigidity. 9629852 1998
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.130 Biomarker phenotype HPO
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.130 Biomarker phenotype HPO
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.120 Biomarker phenotype BEFREE The results confirm that dopaminergic dysfunction in RTT is also present in Mecp2-deficient mice and that reductions in D<sub>2</sub>R more likely explain the impaired ambulation and progressive rigidity observed rather than alterations in DAT. 29782864 2018
Entrez Id: 221927
Gene Symbol: BRAT1
BRAT1
0.120 GeneticVariation phenotype BEFREE Mutations in the BRCA1-associated protein required for the ataxia telangiectasia mutated (ATM) activation-1 (BRAT1) gene cause lethal neonatal rigidity and multifocal seizure syndrome characterized by rigidity and intractable seizures and a milder phenotype with intellectual disability, seizures, nonprogressive cerebellar ataxia or dyspraxia, and cerebellar atrophy. 28635423 2017
Entrez Id: 221927
Gene Symbol: BRAT1
BRAT1
0.120 GeneticVariation phenotype BEFREE Variants in BRAT1 have been identified to cause lethal neonatal rigidity and multifocal seizure syndrome (OMIM# 614498), which consistently manifests a severe neurological phenotype that includes neonatal presentation of rigidity and hypertonia, microcephaly and arrested head growth, intractable seizures, absence of developmental progress, apneic episodes, and death usually by 6 months of age. 26494257 2016
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.120 GeneticVariation phenotype BEFREE Based on motor Unified Parkinson's Disease Rating Scale subscores, MAPT (P = .0002) and CCDC62 (P = .003) were predominantly associated with bradykinesia, and we further discovered associations between SREBF1 (rs11868035; P = .005) and gait impairment, SNCA (rs356220; P = .04) and rigidity, and GAK (rs1564282; P = .03) and tremor. 24514572 2014